Company Profile

Home
Markets
Company Profile

Vodafone Idea

8.57 19.15(%)

Hind.Aeronautics

4,492.80 5,675.00(%)

HBL Engineering

532.15 738.65(%)

Reliance Industr

1,250.00 1,156.00(%)

HDFC Bank

1,765.00 1,430.15(%)

Overview
Key Ratios
Financials
Shareholding
Company Info
Peer Comparison

Lupin Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

Indian Private
BSE Code : 3026.0
ISIN : INE326A01037

1,955.40 -73 (-3.58%)

As on 01 Apr 2025 (EOD)

Today’s Low
1,944.05
Today’s High
2,021.95

Open
2,017.65
Perv Close
2,027.95
52W Low
1,493.30
52W High
2,402.90

Key Indicators

P/E(TTM)

28.55
Mar.Cap (₹Cr.)

89,276.73
Div & Yield %

0.41
Book Value(₹)

481.38
Debt-Equity Ratio

-3.58
AGM Date

01-Apr-2025
EPS

68.52
P/E Ratio

28.55

Financials Ratios

Debt-Equity Ratio

0.28
Mar.Cap (₹Cr.)

89,276.73

RONW (%)

14.47
ROCE (%)

15.34

Score Board

Equity (₹ in Cr.)

91.31
BV (₹)

481.40
Sales( ₹ in Cr.)

14,666.50
NP (in Cr.)

2,302.84
NP Var(%)

461.0
Div%

400.0
CPS (₹)

66.30
EPS (₹)

50.40
Traded Value (₹ in Lakhs)

89,322.39

52 Week High

2,402.90
52 Week Low

1,493.30
Price BSE

1956.0
Price NSE

1,955.00
Market Capital( in Cr.)

89,322.39
P/C Ratio

29.50
P/E Ratio

38.80
Price Vs.BV

50.40

21-Mar-2025( 07:12)

Corporate News - Nanom... - <P>Nanomi B.V., a Dutch subsid...
21-Mar-2025( 04:10)

Corporate News - Lupin... - Lupin has allotted 24,101 equi...
17-Mar-2025( 01:36)

Corporate News - Lupin... - <P>Lupin has received tentativ...
17-Mar-2025( 10:44)

Hot Pursuit - Lupin... - <p> Amifampridine Tablets, 10...

Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)

Particulars(INCOME)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Sales Turnover	14,666.50	11,258.83	11,771.67	11,055.93	11,025.66	11,356.32
Excise Duty	13,953.11	10,779.78	10,691.46	10,873.67	10,629.06	10,657.32
Net Sales	14,666.50	11,258.83	11,771.67	11,055.93	11,025.66	11,356.32
Other Income	115.51	210.02	216.99	129.09	475.19	291.34
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	14,782.01	11,468.85	11,988.66	11,185.02	11,500.85	11,647.66
EXPENDITURE :
Raw Materials	13,953.11	10,779.78	10,691.46	10,873.67	10,629.06	10,657.32
Power & Fuel Cost	13,953.11	10,779.78	10,691.46	10,873.67	10,629.06	10,657.32
Employee Cost	2,095.51	1,934.14	1,918.16	1,695.86	1,703.22	1,515.42
Other Manufacturing Expenses	200.31	162.95	1,976.35	253.36	124.90	139.47
Selling & Administrative Expenses	2,268.24	1,797.13	1,573.22	1,355.01	1,557.70	1,488.58
Miscellaneous Expenses	200.31	162.95	1,976.35	253.36	124.90	139.47
Less : Pre-operative Expenses Capitalised :
Total Expenditure	11,997.32	10,941.71	12,150.19	9,555.32	9,689.39	8,965.31
Operating Profit	1,626.93	1,603.02	1,627.54	1,525.33	1,524.96	1,467.17
Interest	56.35	98.44	73.47	40.62	52.59	35.47
Gross Profit	2,784.69	527.14	-161.53	1,629.70	1,052.25	2,342.37
Depreciation	724.75	548.34	514.19	502.83	518.75	426.30
Profit Before Tax	2,784.69	527.14	-161.53	1,629.70	1,052.25	2,342.37
Tax	484.05	95.89	57.80	367.10	367.90	803.10
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-25.45	6.04	-30.63	8.23	-37.35	8.54
Reported Net Profit	2,326.09	425.21	-188.70	1,258.62	727.55	1,538.83
Extraordinary Items	2,784.69	527.14	-161.53	1,629.70	1,052.25	2,342.37
Adjusted Net Profit	2,326.09	425.21	-188.70	1,258.62	727.55	1,538.83
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	0.00	0.00	0.00	0.00	0.00	0.00
Statutory Appropriations	364.60	181.99	181.80	294.92	271.84	226.25
P & L Balance carried down	2,326.09	425.21	-188.70	1,258.62	727.55	1,538.83
Dividend	-	-	-	-	-	-
Preference Dividend	-	-	-	-	-	-
Equity Dividend (%)	400.00	200.00	200.00	325.00	300.00	250.00
Dividend Per Share(Rs)	8.00	4.00	4.00	6.50	6.00	5.00
Earnings Per Share-Unit Curr	51.10	9.35	-4.16	27.77	16.07	34.03
Book Value	364.60	181.99	181.80	294.92	271.84	226.25
Book Value(Adj)-Unit Curr	364.60	181.99	181.80	294.92	271.84	226.25

Shareholding Pattern

Promoter Group

46.95%
Public Share Holding

53.05%

Category of Shareholder	No of Shares	% Holdings	Demat Shares	Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	1,286,394	1,286,394.00	1,286,394	1,286,394
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0
Sub Total	1,286,394	0.28	1,286,394	3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group)	207,194,390	45.41	207,194,390	1
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	5,725,730	1.26	5,725,730	7
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	1,000	0.00	1,000	1
Others	0	0.00	0	0
Sub Total	212,921,120	46.67	212,921,120	9
Total ShareHolding for Promoter & Group	214,207,514	46.95	214,207,514	12
B]. Publice Share Holding
1] Institution
Government(Central / State)	35,632	0.01	35,632	3
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	16,156	0.00	14,656	9
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	100,563,863	22.04	100,563,863	861
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	29,230,782	6.41	29,230,782	32
Mutual Funds / UTI	77,208,998	16.92	77,206,398	35
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	6,397,806	1.40	6,397,806	24
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0
Sub total	213,453,237	46.79	213,449,137	964
2] Non Institution
Bodies Corporate	1,381,607	0.30	1,375,607	1,109
Clearing Members	90,724	0.02	90,724	14
Directors of their Relatives	37,232	0.01	37,232	1
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	5,000	0.00	5,000	1
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	1,577,316	0.35	1,576,916	7,835
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	541,927	0.12	541,927	3,894
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	267,300	0.06	267,300	2
Individuals holding nominal share capital up to Rs. 1 lakh	23,302,619	5.11	22,762,378	268,030
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	17,553	0.00	17,553	18
Others	1,233,608	0.27	1,233,608	4
Sub Total	28,573,791	6.26	28,024,450	281,012
Total Public Shareholding	213,453,243.26	53.05	241,473,587	281,976
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0
Total Shares held by Custodians and against which Depository Receipts have been issued	0	0.00	0	0
Grand Total ( A + B + C )	456,234,542	100.00	455,681,101	281,988

Company Background

Lupin LtdPharmaceuticals - Indian - Bulk Drugs & Formln

Lupin Ltd
BSE Code : 3026.0
ISIN : INE326A01037

Incorporation Year

1983
Registered Office

Kalpataru Inspire 3rd Floor
Off Western Exp HW Santacruz-E, Mumbai,
Maharashtra-400055
Telephone

91-22-6640 2323
FAX

91-22-6640 8131
Chairman

M D Gupta
Managing Director

Nilesh Deshbandhu Gupta.
Company Secretary

R V Satam
Auditor

B S R & Co LLP
Face Value

2
Listing

NSE
Registrar

MUFG Intime India Pvt Ltd
C-101 247 Park,
L B S Marg,Vikhroli West
Mumbai - Mumbai-400083

Lupin Ltd Peer Comparison

Profit & Loss

Financial Ratios

Balance Sheet

Company Name	LTP (₹)	Revenue	Sales	P/E Ratio	ROCE %
Lupin	1,956.40	14,782.01	14,666.50	29.13	13.96
Abbott India	30,305.85	6,097.18	5,848.91	48.26	44.71
Astrazeneca Phar	8,518.55	1,330.33	1,295.53	219.61	33.26
P & G Health Ltd	5,152.30	1,166.89	1,151.26	36.15	39.76
Glaxosmi. Pharma	2,793.40	3,530.73	3,407.25	55.55	44.44
Cipla	1,444.55	17,645.00	16,574.34	24.77	20.10
Amrutanjan Healt	642.85	437.58	421.23	37.68	20.84
Fermenta Biotec.	285.30	315.24	307.09	27.04	4.10
Guj. Themis Bio.	271.85	174.19	169.82	56.28	44.82
Bliss GVS Pharma	119.25	638.96	605.46	27.29	11.19
Ambalal Sarabhai	36.15	11.70	3.81	15.45	1.92